Luris Higuera

Luris Higuera is the president of the Advocacy Commission of the Panamanian Rheumatoid Arthritis Foundation (Funarp), where she has been vocal about the challenges faced by patients with rheumatoid arthritis, particularly regarding the ineffectiveness of the biosimilar drug Rixathon and its impact on patient health and treatment costs.